FDA Reg. for Investigational Devices Flashcards
Humanitarian Device Exemption
manufacturer does not need to provide evidence of efficacy
restrictions on profitability
can only be used in a facility after an IRB has approved their use in that facility, except in certain emergencies
Humanitarian Use Device
a device that is intended to benefit subjects in the treatment or diagnosis of a disease or condition affecting fewer than 8,000 individuals in the U.S. per year
Investigational Device Exemption
an approved IDE means that the IRB (and FDA for significant risk [SR] devices) has approved the sponsor’s study application as meeting the requirements under 21 CFR 812 (Investigational Device Exemptions 2014).
Institutional Review Board
any board, committee, or other group formally designated by an institution to review, to approve the initiation of, and to conduct periodic review of, biomedical research involving human subjects. The primary purpose of such review is to assure the protection of the rights and welfare of the human subjects.
Medical Device
an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory, which is:
Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease in humans or other animals.
Intended to affect the structure or any function of the body of humans or other animals.
Recognized in the official National Formulary, the United States Pharmacopoeia, or any supplement to them (Federal Food, Drug, and Cosmetic Act 2012).
A medical device does not achieve any of its primary intended purposes through chemical action within or on humans or other animals and is not dependent upon being metabolized for the achievement of any of its primary intended purposes.
Non-Significant Risk
a device that does not pose a significant risk to subjects
Significant Risk
sutures, cardiac pacemakers, hydrocephalus shunts, and orthopedic implants
Transitional Devices
regulated by FDA as new drugs before 28 May 1976
21 CFR 50
Protection of Human Subjects
Provides the requirements and general elements of informed consent.
21 CFR 56
Institutional Review Boards
Covers the procedures and responsibilities for IRBs that approve clinical investigational protocols.
21 CFR 54
Financial Disclosure by Clinical Investigators
Covers the disclosure of possible financial conflicts of interest by clinical investigators.
21 CFR 803
Medical Device Reporting
Covers reporting of adverse events (AEs) for approved products (and HUDs).
21 CFR 812
Investigational Device Exemptions [IDE]
Covers the procedures for the conduct of clinical studies with medical devices, including application, responsibilities of sponsors and investigators, labeling, records, and reports.
21 CFR 814
Premarket Approval of Devices
Covers the procedure for obtaining approval to market certain devices and HDEs.
21 CFR 820, Subpart C
Design Controls of the Quality System Regulation
Details requirements to ensure that specified design requirements are met.